Clinical trial
Teicoplanin in Treating Septicemia in Patients Who Are Receiving Chemotherapy…
NCT00024453 · Children's Cancer and Leukaemia Group, Other · Unknown status
Key facts
| NCT number | NCT00024453 |
|---|---|
| Title | Teicoplanin in Treating Septicemia in Patients Who Are Receiving Chemotherapy Through a Central Venous Catheter |
| Official title | The Use of Teicoplanin in the Treatment of Septicaemia Caused by Coagulase-Negative Staphylococci - A Randomized Study Comparing Bolus Injection With Infused and/or Line-Locked Teicoplanin |
| Lead sponsor | Children's Cancer and Leukaemia Group, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Infection |
| Intervention type | Biological |
| Interventions | teicoplanin |
| Enrollment | 1,360 |
| Start date | Feb 1, 1999 |
| Primary completion | Dec 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 7, 2013 |
| Countries | Ireland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: